Skip to content

AtriCure ATRC Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$1.83M+160%
ITG
Integer HoldingsITGR
-$30.65M-30.4%
Avanos Medical logo
Avanos MedicalAVNS
-$33.7M-128%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
-$10.31M-319%

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's change in accrued liabilities?
AtriCure (ATRC) reported change in accrued liabilities of -$13.51M in Q1 2026.
How has AtriCure's change in accrued liabilities changed year-over-year?
AtriCure's change in accrued liabilities decreased by 7.5% year-over-year, from -$12.56M to -$13.51M.
What is the long-term trend for AtriCure's change in accrued liabilities?
Over 2 years (2021 to 2025), AtriCure's change in accrued liabilities has grown at a -10.9% compound annual growth rate (CAGR), from $8.81M to $7M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.